Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(S)-benzyl 2-(2-(4-hydroxynaphthalen-1-ylcarbamoyl)pyrrolidin-1-yl)-2-oxoethylcarbamate + H2O
?
-
specific substrate, UAMC-00682
-
-
?
alpha-melanocyte-stimulating hormone + H2O
?
-
-
-
-
?
angiotensin I + H2O
?
-
-
-
-
?
angiotensin II + H2O
?
-
-
-
-
?
arginine-vasopressin + H2O
?
-
-
-
-
?
benzyloxycarbonyl-Gly-Pro-2-naphthylamide + H2O
benzyloxycarbonyl-Gly-Pro + 2-naphthylamine
-
-
-
?
beta-endorphin + H2O
?
-
-
-
-
?
bradykinin + H2O
?
-
-
-
-
?
bradykinin potentiating peptide + H2O
?
-
-
-
-
?
Gly-L-Pro-4-nitroanilide + H2O
Gly-L-Pro + 4-nitroaniline
-
-
-
-
?
gonadotropin releasing hormone + H2O
?
-
-
-
-
?
Luliberin + H2O
?
-
-
-
-
?
melanotropin + H2O
?
-
-
-
-
?
N-carbobenzyloxy-Ala-Pro-2-naphthylamide + H2O
N-carbobenzyloxy-Ala-Pro + 2-naphthylamine
-
-
-
-
?
N-succinyl-glycyl-proline-4-methylcoumarin-7-amide + H2O
N-succinyl-glycyl-proline + 7-amino-4-methylcoumarin
-
-
-
-
?
N-succinyl-glycyl-prolyl-7-amido-4-methylcoumarin + H2O
N-succinyl-glycyl-prolyl + 7-amino-4-methylcoumarin
-
-
-
-
?
neurotensin + H2O
?
-
-
-
-
?
oxytocin + H2O
?
-
-
-
-
?
oxytoxin + H2O
?
-
-
-
-
?
somatostatin-28 (1-12) + H2O
?
-
-
-
-
?
Substance P + H2O
?
-
-
-
-
?
succinyl-Gly-L-Pro-7-amido-4-methylcoumarin + H2O
succinyl-Gly-L-Pro + 7-amino-4-methylcoumarin
-
-
-
-
?
thymosin beta4 + H2O
acetyl-N-Ser-Asp-Lys-Pro + ?
-
prolyl oligopeptidase is a second-step enzyme in the release of acetyl-N-Ser-Asp-Lys-Pro from thymosin beta4 and has autoregulatory effect in the first step
-
-
?
thyroliberin + H2O
?
-
-
-
-
?
thyrotropin releasing hormone + H2O
?
-
-
-
-
?
tuftsin + H2O
?
-
-
-
-
?
Vasopressin + H2O
?
-
-
-
-
?
additional information
?
-
additional information
?
-
prolyl oligopeptidase binds to the growth-38 associated protein GAP-43, which is a key regulator of synaptic plasticity
-
-
?
additional information
?
-
-
tissue-dependent peptide hydrolysis evoked by prolyl endopeptidase activity is involved in the water-electrolyte homeostasis
-
?
additional information
?
-
-
cellular functions, overview, POP may regulate phosphoinositide signaling, overview
-
-
?
additional information
?
-
-
the enzyme in the brain dopaminergix system is involved in the pathogenesis of doamine deficiency-dependent depressive states, and is activated in association with development of MPTP-induced depressive syndrome in the brain frontal cortex, overview
-
-
?
additional information
?
-
-
the enzyme is a serine protease, that digests small peptide-like hormones, neuroactive peptides, and various cellular factors, it is implicated in several biological processes and diseases, e.g. in some psychiatric disorders, most probably through interference in the inositol cycle, it is important in the metabolism of substance P, arginine vasopressin, thyroliberin, and gonadoliberin, enzyme regulation, overview
-
-
?
additional information
?
-
-
the enzyme is associated with cognitive functions and inositol 1,4,5-triphosphate signaling, and plays a role in modifying neuropeptide levels, overview
-
-
?
additional information
?
-
-
the enzyme is involved in the phosphoinositide pathway, in formation and processing of amyloid beta-peptide, protein secretion, and in neuronal differentiation and maturation, overview, the enzyme is involved in several diseases, e.g. celiac disease, Alzheimer's diease, Parkinsons's disease, affective disorders, eating disorders, cancer, inflammation, hypertension, and neurodegenarative disorders, overview, enzyme inhibition can improve the retention time when administered before either the acquisition or the retential trial in scopolamine-induced amnesia, enzyme inhibition also positively affects neurodiseases, overview
-
-
?
additional information
?
-
-
the enzyme is involved with the inactivation of regulatory neuropeptides
-
-
?
additional information
?
-
-
the enzyme plays a role in inositol 1,4,5-triphosphate signaling and in the actions of antidepressants, POP inhibitors have antiamnesic and neuroprotective properties, overview
-
-
?
additional information
?
-
-
no activity with gluten in celiac sprue rats, substrate specificity with exclusion of peptides with more than 30 amino acids, overview
-
-
?
additional information
?
-
-
substrate specificity, overview, the enzyme cleaves at the C-terminal side of proline residues and more slowly of alanine residues, no activity with large proteins with over 30 amino acids
-
-
?
additional information
?
-
-
the enzyme hydrolyzes the peptide bond on the carboxyl side of internal proline residues of oligopeptide substrates with up to 30 amino acids, substrate specificity, overview
-
-
?
additional information
?
-
-
the enzyme shows endopeptidase activity with peptides no longer than 3 amino acids
-
-
?
additional information
?
-
-
the serine protease cleaves at the C-terminal side of proline residues and more slowly of alanine residues of peptides with no more than 30 amino acids
-
-
?
additional information
?
-
-
hydrolyzes proline-containing peptides shorter than 30 amino acids
-
-
?
additional information
?
-
-
is involved in thalamocortical and corticothalamic signal processing
-
-
?
additional information
?
-
-
the recombinant prolyl oligopeptidase is not able to cleave whole 43-mer thymosin beta4, while it is effective at hydrolyzing somatostatin-28 (1-12)
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
alpha-melanocyte-stimulating hormone + H2O
?
-
-
-
-
?
angiotensin I + H2O
?
-
-
-
-
?
angiotensin II + H2O
?
-
-
-
-
?
arginine-vasopressin + H2O
?
-
-
-
-
?
beta-endorphin + H2O
?
-
-
-
-
?
bradykinin + H2O
?
-
-
-
-
?
bradykinin potentiating peptide + H2O
?
-
-
-
-
?
gonadotropin releasing hormone + H2O
?
-
-
-
-
?
Luliberin + H2O
?
-
-
-
-
?
melanotropin + H2O
?
-
-
-
-
?
neurotensin + H2O
?
-
-
-
-
?
oxytocin + H2O
?
-
-
-
-
?
oxytoxin + H2O
?
-
-
-
-
?
Substance P + H2O
?
-
-
-
-
?
thyroliberin + H2O
?
-
-
-
-
?
thyrotropin releasing hormone + H2O
?
-
-
-
-
?
tuftsin + H2O
?
-
-
-
-
?
Vasopressin + H2O
?
-
-
-
-
?
additional information
?
-
additional information
?
-
prolyl oligopeptidase binds to the growth-38 associated protein GAP-43, which is a key regulator of synaptic plasticity
-
-
?
additional information
?
-
-
tissue-dependent peptide hydrolysis evoked by prolyl endopeptidase activity is involved in the water-electrolyte homeostasis
-
?
additional information
?
-
-
cellular functions, overview, POP may regulate phosphoinositide signaling, overview
-
-
?
additional information
?
-
-
the enzyme in the brain dopaminergix system is involved in the pathogenesis of doamine deficiency-dependent depressive states, and is activated in association with development of MPTP-induced depressive syndrome in the brain frontal cortex, overview
-
-
?
additional information
?
-
-
the enzyme is a serine protease, that digests small peptide-like hormones, neuroactive peptides, and various cellular factors, it is implicated in several biological processes and diseases, e.g. in some psychiatric disorders, most probably through interference in the inositol cycle, it is important in the metabolism of substance P, arginine vasopressin, thyroliberin, and gonadoliberin, enzyme regulation, overview
-
-
?
additional information
?
-
-
the enzyme is associated with cognitive functions and inositol 1,4,5-triphosphate signaling, and plays a role in modifying neuropeptide levels, overview
-
-
?
additional information
?
-
-
the enzyme is involved in the phosphoinositide pathway, in formation and processing of amyloid beta-peptide, protein secretion, and in neuronal differentiation and maturation, overview, the enzyme is involved in several diseases, e.g. celiac disease, Alzheimer's diease, Parkinsons's disease, affective disorders, eating disorders, cancer, inflammation, hypertension, and neurodegenarative disorders, overview, enzyme inhibition can improve the retention time when administered before either the acquisition or the retential trial in scopolamine-induced amnesia, enzyme inhibition also positively affects neurodiseases, overview
-
-
?
additional information
?
-
-
the enzyme is involved with the inactivation of regulatory neuropeptides
-
-
?
additional information
?
-
-
the enzyme plays a role in inositol 1,4,5-triphosphate signaling and in the actions of antidepressants, POP inhibitors have antiamnesic and neuroprotective properties, overview
-
-
?
additional information
?
-
-
hydrolyzes proline-containing peptides shorter than 30 amino acids
-
-
?
additional information
?
-
-
is involved in thalamocortical and corticothalamic signal processing
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(S)-1-((S)-1-(4-phenylbutanoyl)-pyrrolidine-2-carbonyl)pyrrolidine-2-carbonitrile
-
KYP-2047, most potent inhibitor
1,2-oxazolidin-2-yl[(2S,3aS,7aS)-1-[[(1R,2R)-2-phenylcyclopropyl]carbonyl]octahydro-1H-indol-2-yl]methanone
-
-
1-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]octan-1-one
-
-
1-[2-oxo-2-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]ethyl]-3-phenylquinoxalin-2(1H)-one
-
-
2,3-dihydro-1H-pyrrol-1-yl[(2S,3aS,7aS)-1-[[(1R,2R)-2-phenylcyclopropyl]carbonyl]octahydro-1H-indol-2-yl]methanone
-
-
2,5-dihydro-1H-pyrrol-1-yl[(2S,3aS,7aS)-1-[[(1R,2R)-2-phenylcyclopropyl]carbonyl]octahydro-1H-indol-2-yl]methanone
-
-
2-[2-oxo-2-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]ethyl]-1H-isoindole-1,3(2H)-dione
-
-
2-[2-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-2-oxoethyl]-1H-isoindole-1,3(2H)-dione
-
-
3-[3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl]-5,5-diphenylimidazolidine-2,4-dione
-
-
4-phenyl-butanoyl-L-prolyl-2(S)-cyanopyrrolidine
-
KYP-204, 0.1 mM and 0.5 mM concentrations significantly inhibit enzyme activity in tissue homogenate
aesculitannin B
-
noncompetitive
benzyloxycarbonyl-L-methionyl-2(S)-cyanopyrrolidine
-
-
benzyloxycarbonyl-Pro-prolinal
-
i.e. Z-Pro-prolinal
Boc-Asn-Phe-Pro-aldehyde
-
-
buspirone
-
25% inhibition at 0.01 mM
chlorpromazine
-
55% inhibition at 0.01 mM
citalopram
-
27% inhibition at 0.01 mM
clozapine
-
40% inhibition at 0.01 mM
desipramine
-
20% inhibition at 0.01 mM
diisopropyl fluorophosphate
-
enzyme from brain and skin
duloxetine
-
21% inhibition at 0.01 mM
epicatechin
-
noncompetitive
escitalopram
-
39% inhibition at 0.01 mM
flupenthixol
-
56% inhibition at 0.01 mM
imipramine
-
29% inhibition at 0.01 mM
iodoacetamide
-
enzyme from brain
iodoacetate
-
enzyme from brain
isolinderalactone
-
competitive
ketanserin
-
mixed type inhibitor, 49% inhibition at 0.01 mM
lamotrigine
-
22% inhibition at 0.01 mM
levomepromazine
-
32% inhibition at 0.01 mM
linderalactone
-
competitive
linderene acetate
-
competitive
mianserin
-
15% inhibition at 0.01 mM
NEM
-
enzyme from brain and skin
PCMB
-
enzyme from brain and skin
pimozide
-
11% inhibition at 0.01 mM
PMSF
-
enzyme from brain and partly enzyme from skin
prazosin
-
91% inhibition at 0.01 mM
prochlorperazine
-
77% inhibition at 0.01 mM
promazine
-
64% inhibition at 0.01 mM
reboxetine
-
13% inhibition at 0.01 mM
reserpine
-
18% inhibition at 0.01 mM
risperidone
-
56% inhibition at 0.01 mM
ritanserin
-
33% inhibition at 0.01 mM
thioridazine
-
non-competitive inhibitor, 91% inhibition at 0.01 mM
tosyllysylchloromethane
-
enzyme from brain
tosylphenylalanylchloromethane
-
enzyme from brain, partly
Valproate
-
competitive inhibitor, 56% inhibition at 0.5 mM
Z-Pro-Pro-aldehyde-dimethylacetal
-
-
Z-thioprolyl-thioprolinal-dimethylacetal
-
physiological effects, overview
[(1R,2R)-2-phenylcyclopropyl][(2S,3aS,7aS)-2-(1H-pyrrol-1-ylcarbonyl)octahydro-1H-indol-1-yl]methanone
-
-
[(1R,2R)-2-phenylcyclopropyl][(2S,3aS,7aS)-2-(pyrrolidin-1-ylcarbonyl)octahydro-1H-indol-1-yl]methanone
-
-
[(1R,2R)-2-phenylcyclopropyl][(3S)-3-(pyrrolidin-1-ylcarbonyl)-2-azabicyclo[2.2.2]oct-2-yl]methanone
-
-
JTP-4819
-
-
JTP-4819
-
a selective POP inhibitor, physiological effects, overview
JTP-4819
-
i.e. (S)-2-[[(S)-2-(hydroxyacetyl)-1-yrrolidinyl]carbonyl]-N-(phenylmethyl)-1-pyrrolidinecarboxamide, improves learning deficits in rats with dorsal hippocampal lesions
S 17092
-
physiological effects, overview
S 17092
-
selective enzyme inhibitor, pharmacodynamics and pharmacokinetics, overview
S-17092
-
-
S-17092
-
i.e. (2S,3aS,7aS)-1-[[(R,R)-2-phenylcyclopropyl]carbonyl]-2-[(thiazolidin-3-yl)carbonyl] octahydro-1H-indole
Z-Pro-prolinal
-
-
Z-Pro-prolinal
-
physiological effects, overview
ZTTA
-
-
ZTTA
-
i.e. N-benzyloxycarbonyl-thioprolyl-thioprolinal-dimethylacetal
additional information
-
no inhibition by lithium, carbamazepime, desipramine, fluoxetine, and olanzapine
-
additional information
-
structure-function relationship of inhibitors, specificity at the P2 and S3 position, overview
-
additional information
-
not inhibited by carbamazepine, bupropion, diazepam, fluoxetine, haloperidol, lithium, maprotiline, mirtazapine, moclobemide, pargyline, pinoline, scopolamine, selegiline, sulpiride, venlafaxine, and valpraote at 0.01 mM concentration
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.00000029
(S)-1-((S)-1-(4-phenylbutanoyl)-pyrrolidine-2-carbonyl)pyrrolidine-2-carbonitrile
Rattus norvegicus
-
cell free assay, pH and temperature not specified in the publication
0.000002
1,2-oxazolidin-2-yl[(2S,3aS,7aS)-1-[[(1R,2R)-2-phenylcyclopropyl]carbonyl]octahydro-1H-indol-2-yl]methanone
Rattus norvegicus
-
rat cortex
0.00002
1-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]octan-1-one
Rattus norvegicus
-
rat brain
0.00000088
1-[2-oxo-2-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]ethyl]-3-phenylquinoxalin-2(1H)-one
Rattus norvegicus
-
rat brain
0.0000027
2,3-dihydro-1H-pyrrol-1-yl[(2S,3aS,7aS)-1-[[(1R,2R)-2-phenylcyclopropyl]carbonyl]octahydro-1H-indol-2-yl]methanone
Rattus norvegicus
-
rat cortex
0.0000024
2,5-dihydro-1H-pyrrol-1-yl[(2S,3aS,7aS)-1-[[(1R,2R)-2-phenylcyclopropyl]carbonyl]octahydro-1H-indol-2-yl]methanone
Rattus norvegicus
-
rat cortex
0.000003
2-[2-oxo-2-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]ethyl]-1H-isoindole-1,3(2H)-dione
Rattus norvegicus
-
rat brain
0.00000081
2-[2-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-2-oxoethyl]-1H-isoindole-1,3(2H)-dione
Rattus norvegicus
-
rat brain
0.000041
3-[3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl]-5,5-diphenylimidazolidine-2,4-dione
Rattus norvegicus
-
rat brain
0.00204
Boc-Asn-Phe-Pro-aldehyde
Rattus norvegicus
-
cell free assay, pH and temperature not specified in the publication
0.00000083
JTP-4819
Rattus norvegicus
-
rat brain
0.0000072
SUAM-1221
Rattus norvegicus
-
rat brain
0.000733
Z-Pro-Pro-aldehyde-dimethylacetal
Rattus norvegicus
-
cell free assay, pH and temperature not specified in the publication
0.0000023
[(1R,2R)-2-phenylcyclopropyl][(2S,3aS,7aS)-2-(1H-pyrrol-1-ylcarbonyl)octahydro-1H-indol-1-yl]methanone
Rattus norvegicus
-
rat cortex
0.0000012
[(1R,2R)-2-phenylcyclopropyl][(2S,3aS,7aS)-2-(pyrrolidin-1-ylcarbonyl)octahydro-1H-indol-1-yl]methanone
Rattus norvegicus
-
rat cortex
0.000005
[(1R,2R)-2-phenylcyclopropyl][(3S)-3-(pyrrolidin-1-ylcarbonyl)-2-azabicyclo[2.2.2]oct-2-yl]methanone
Rattus norvegicus
-
rat cortex
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Kobayashi, W.; Miyase, T.; Sano, M.; Umehara, K.; Warashina, T.; Noguchi, H.
Prolyl endopeptidase inhibitors from the roots of Lindera strychnifolia F. Vill
Biol. Pharm. Bull.
25
1049-1052
2002
Elizabethkingia meningoseptica, Rattus norvegicus
brenda
Irazusta, J.; Silveira, P.F.; Gil, J.; Varona, A.; Casis, L.
Effects of hydrosaline treatments on prolyl endopeptidase activity in rat tissues
Regul. Pept.
101
141-147
2001
Rattus norvegicus
brenda
Besedin, D.V.; Rudenskaya, G.N.
Proline-specific endopeptidases
Russ. J. Bioorg. Chem.
29
1-17
2003
Agaricus bisporus, Bos taurus, Cavia porcellus, Gallus gallus, Elizabethkingia meningoseptica, Oryctolagus cuniculus, Novosphingobium capsulatum, Ovis aries, Homo sapiens, Lyophyllum cinerascens, Mus musculus, Rattus norvegicus, Sus scrofa, Xanthomonas sp., Ascidia sp., Clupea pallasii, Lactifluus hygrophoroides, Russula lepida
-
brenda
Krupina, N.A.; Zolotov, N.N.; Bogdanova, N.G.; Orlova, I.N.; Khlebnikova, N.N.; Kryzhanovskii, G.N.
Activities of prolyl endopeptidase and dipeptidyl peptidase IV in brain structures of rats with dopamine deficiency-dependent MPTP-induced depressive syndrome
Bull. Exp. Biol. Med.
142
554-556
2006
Rattus norvegicus
brenda
Gass, J.; Khosla, C.
Prolyl endopeptidases
Cell. Mol. Life Sci.
64
345-355
2007
Elizabethkingia meningoseptica, Dictyostelium discoideum, Novosphingobium capsulatum, Homo sapiens, Mus musculus, Myxococcus xanthus, Pyrococcus furiosus, Rattus norvegicus, Sus scrofa
brenda
Brandt, I.; Scharpe, S.; Lambeir, A.M.
Suggested functions for prolyl oligopeptidase: a puzzling paradox
Clin. Chim. Acta
377
50-61
2007
Elizabethkingia meningoseptica, Homo sapiens, Mus musculus, Rattus norvegicus, Trypanosoma cruzi
brenda
Szeltner, Z.; Polgar, L.
Structure, function and biological relevance of prolyl oligopeptidase
Curr. Protein Pept. Sci.
9
96-107
2008
Elizabethkingia meningoseptica, Dictyostelium discoideum, Novosphingobium capsulatum, Homo sapiens, Platyrrhini, Mus musculus, Myxococcus xanthus, Pyrococcus furiosus, Rattus norvegicus, Sus scrofa
brenda
Myoehaenen, T.T.; Venaelaeinen, J.I.; Garcia-Horsman, J.A.; Piltonen, M.; Maennistoe, P.T.
Cellular and subcellular distribution of rat brain prolyl oligopeptidase and its association with specific neuronal neurotransmitters
J. Comp. Neurol.
507
1694-1708
2008
Rattus norvegicus
brenda
Myoehaenen, T.T.; Venaelaeinen, J.I.; Tupala, E.; Garcia-Horsman, J.A.; Miettinen, R.; Maennistoe, P.T.
Distribution of immunoreactive prolyl oligopeptidase in human and rat brain
Neurochem. Res.
32
1365-1374
2007
Homo sapiens, Rattus norvegicus
brenda
Garcia-Horsman, J.A.; Maennistoe, P.T.; Venaelaeinen, J.I.
On the role of prolyl oligopeptidase in health and disease
Neuropeptides
41
1-24
2007
Dictyostelium discoideum, Novosphingobium capsulatum, Flavobacterium sp., Homo sapiens, Mus musculus, Rattus norvegicus, Sus scrofa (P23687)
brenda
Di Daniel, E.; Glover, C.P.; Grot, E.; Chan, M.K.; Sanderson, T.H.; White, J.H.; Ellis, C.L.; Gallagher, K.T.; Uney, J.; Thomas, J.; Maycox, P.R.; Mudge, A.W.
Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity
Mol. Cell. Neurosci.
41
373-382
2009
Rattus norvegicus (O70196)
brenda
Myoehaenen, T.T.; Kaeaeriaeinen, T.M.; Jalkanen, A.J.; Piltonen, M.; Maennistoe, P.T.
Localization of prolyl oligopeptidase in the thalamic and cortical projection neurons: a retrograde neurotracing study in the rat brain
Neurosci. Lett.
450
201-205
2009
Rattus norvegicus
brenda
Myoehaenen, T.T.; Venaelaeinen, J.I.; Garcia-Horsman, J.A.; Maennistoe, P.T.
Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its neurokinin-1 receptor in the rat brain: an immunohistochemical colocalization study
Neuroscience
153
1177-1189
2008
Rattus norvegicus
brenda
Tenorio-Laranga, J.; Valero, M.L.; Maennistoe, P.T.; Sanchez del Pino, M.; Garcia-Horsman, J.A.
Combination of snap freezing, differential pH two-dimensional reverse-phase high-performance liquid chromatography, and iTRAQ technology for the peptidomic analysis of the effect of prolyl oligopeptidase inhibition in the rat brain
Anal. Biochem.
393
80-87
2009
Rattus norvegicus
brenda
Peltonen, I.; Jalkanen, A.J.; Sinervae, V.; Puttonen, K.A.; Maennistoe, P.T.
Different effects of scopolamine and inhibition of prolyl oligopeptidase on mnemonic and motility functions of young and 8- to 9-month-old rats in the radial-arm maze
Basic Clin. Pharmacol. Toxicol.
106
280-287
2010
Rattus norvegicus
brenda
Khlebnikova, N.N.; Krupina, N.A.; Bogdanova, N.G.; Zolotov, N.N.; Kryzhanovskii, G.N.
Effects of prolylendopeptidase inhibitor benzyloxycarbonyl-methionyl-2(S)-cyanopyrrolidine on experimental depressive syndrome development in rats
Bull. Exp. Biol. Med.
147
26-30
2009
Rattus norvegicus
brenda
Khlebnikova, N.N.; Krupina, N.A.; Orlova, I.N.; Bogdanova, N.G.; Zolotov, N.N.; Kryzhanovskii, G.N.
Effect of a prolyl endopeptidase inhibitor benzyloxycarbonyl-alanyl-proline on the development of experimental depressive syndrome in rats
Bull. Exp. Biol. Med.
147
291-295
2009
Rattus norvegicus
brenda
Agirregoitia, N.; Bizet, P.; Agirregoitia, E.; Boutelet, I.; Peralta, L.; Vaudry, H.; Jegou, S.
Prolyl endopeptidase mRNA expression in the central nervous system during rat development
J. Chem. Neuroanat.
40
53-62
2010
Rattus norvegicus (O70196)
brenda
Lawandi, J.; Gerber-Lemaire, S.; Juillerat-Jeanneret, L.; Moitessier, N.
Inhibitors of prolyl oligopeptidases for the therapy of human diseases: Defining diseases and inhibitors
J. Med. Chem.
53
3423-3438
2010
Bos taurus, Canis lupus familiaris, Elizabethkingia meningoseptica, Oryctolagus cuniculus, Homo sapiens, Mus musculus, Rattus norvegicus, Sus scrofa (P23687)
brenda
Peltonen, I.; Maennistoe, P.T.
Effects of diverse psychopharmacological substances on the activity of brain prolyl oligopeptidase
Basic Clin. Pharmacol. Toxicol.
108
46-54
2011
Rattus norvegicus
brenda
Myoehaenen, T.T.; Tenorio-Laranga, J.; Jokinen, B.; Vazquez-Sanchez, R.; Moreno-Baylach, M.J.; Garcia-Horsman, J.A.; Maennistoe, P.T.
Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner
Br. J. Pharmacol.
163
1666-1678
2011
Homo sapiens, Rattus norvegicus
brenda
Hannula, M.J.; Maennistoe, P.T.; Myoehaenen, T.T.
Sequential expression, activity and nuclear localization of prolyl oligopeptidase protein in the developing rat brain
Dev. Neurosci.
33
38-47
2011
Rattus norvegicus
brenda
Klimaviciusa, L.; Jain, R.K.; Jaako, K.; Van Elzen, R.; Gerard, M.; van Der Veken, P.; Lambeir, A.M.; Zharkovsky, A.
In situ prolyl oligopeptidase activity assay in neural cell cultures
J. Neurosci. Methods
204
104-110
2012
Homo sapiens, Rattus norvegicus
brenda